Literature DB >> 21409471

A comparative study of 3 different cartilage repair techniques.

Ulrich Schneider1, Bernhard Schmidt-Rohlfing, Karsten Gavenis, Uwe Maus, Ralf Mueller-Rath, Stefan Andereya.   

Abstract

PURPOSE: The value of cell-free techniques in the treatment of cartilage defects remains under debate. In this study, cartilage repair of full-thickness chondral defects in the knees of Goettinger minipigs was assessed by treatment with a cell-free collagen type-I gel or a collagen type-I gel seeded with autologous chondrocytes. As a control, abrasion arthroplasty was included.
METHODS: In 18 adult Goettinger minipigs, three full-thickness chondral defects were created in one knee of the hind leg. They were either treated with a cell-free collagen gel, a collagen gel seeded with 2 × 10(5)/ml chondrocytes, or left untreated. All animals were allowed unlimited weight bearing. At 6, 12, and 52 weeks, 6 animals were sacrificed. Immediately after recovery, a non-destructive biomechanical testing was performed. The repair tissue quality was evaluated histologically, and the O'Driscoll score was calculated.
RESULTS: After 6 weeks, a high number of cells migrated into the initially cell-free collagen gel. After 1 year, a hyaline-like repair tissue in both groups has been created. As assessed by O'Driscoll scoring and col-II staining, repair tissue quality of the initially cell-free gel was equal to defects treated by cell-seeded collagen gel implantation after 1 year. All untreated control defects displayed a fibrous repair tissue. The mechanical properties represented by the e-modulus were inconsistent in the course of the study.
CONCLUSIONS: The implantation of a cell-free collagen type-I gel can lead to a high-quality repair tissue in the Goettinger minipig that equals a cell-based procedure after 1 year postoperatively. This study demonstrates the high chondrogenic potential of the applied collagen gel, which might help to overcome the disadvantages inherent in conventional cartilage tissue engineering methods.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21409471     DOI: 10.1007/s00167-011-1460-x

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN: 0942-2056            Impact factor:   4.342


  36 in total

1.  Characteristics of human chondrocytes, osteoblasts and fibroblasts seeded onto a type I/III collagen sponge under different culture conditions. A light, scanning and transmission electron microscopy study.

Authors:  M Fuss; E M Ehlers; M Russlies; J Rohwedel; P Behrens
Journal:  Ann Anat       Date:  2000-07       Impact factor: 2.698

2.  Matrix-associated autologous chondrocyte transplantation/implantation (MACT/MACI)--5-year follow-up.

Authors:  Peter Behrens; Thomas Bitter; Bodo Kurz; Martin Russlies
Journal:  Knee       Date:  2006-04-24       Impact factor: 2.199

3.  In vitro comparison of six different matrix systems for the cultivation of human chondrocytes.

Authors:  Karsten Gavénis; Bernhard Schmidt-Rohlfing; Ralf Mueller-Rath; Stefan Andereya; Ulrich Schneider
Journal:  In Vitro Cell Dev Biol Anim       Date:  2006 May-Jun       Impact factor: 2.416

4.  A cell-free collagen type I device for the treatment of focal cartilage defects.

Authors:  Karsten Gavenis; Bernhard Schmidt-Rohlfing; Stefan Andereya; Torsten Mumme; Ulrich Schneider; Ralf Mueller-Rath
Journal:  Artif Organs       Date:  2010-01       Impact factor: 3.094

5.  Human chondrocyte proliferation and matrix synthesis cultured in Atelocollagen gel.

Authors:  Y Uchio; M Ochi; M Matsusaki; H Kurioka; K Katsube
Journal:  J Biomed Mater Res       Date:  2000-05

6.  Local application of a collagen type I/hyaluronate matrix and growth and differentiation factor 5 influences the closure of osteochondral defects in a minipig model by enchondral ossification.

Authors:  Martin Jung; Jens Sascha Tuischer; Consolato Sergi; Tobias Gotterbarm; Jens Pohl; Wiltrud Richter; Hans-Georg Simank
Journal:  Growth Factors       Date:  2006-12       Impact factor: 2.511

7.  BMP-7 protects against progression of cartilage degeneration after impact injury.

Authors:  Mark Hurtig; Susan Chubinskaya; Jim Dickey; David Rueger
Journal:  J Orthop Res       Date:  2009-05       Impact factor: 3.494

Review 8.  Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects.

Authors:  E B Hunziker
Journal:  Osteoarthritis Cartilage       Date:  2002-06       Impact factor: 6.576

9.  Injectable mesenchymal stem cell therapy for large cartilage defects--a porcine model.

Authors:  Kevin B L Lee; James H P Hui; Im Chim Song; Lenny Ardany; Eng Hin Lee
Journal:  Stem Cells       Date:  2007-07-26       Impact factor: 6.277

10.  Evaluation of articular cartilage repair using biodegradable nanofibrous scaffolds in a swine model: a pilot study.

Authors:  Wan-Ju Li; Hongsen Chiang; Tzong-Fu Kuo; Hsuan-Shu Lee; Ching-Chuan Jiang; Rocky S Tuan
Journal:  J Tissue Eng Regen Med       Date:  2009-01       Impact factor: 3.963

View more
  18 in total

1.  Cell-free repair of small cartilage defects in the Goettinger minipig: which defect size is possible?

Authors:  K Gavenis; U Schneider; U Maus; T Mumme; R Muller-Rath; Bernhard Schmidt-Rohlfing; S Andereya
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-12-28       Impact factor: 4.342

2.  In Vitro Analysis of Cartilage Regeneration Using a Collagen Type I Hydrogel (CaReS) in the Bovine Cartilage Punch Model.

Authors:  Victoria Horbert; Long Xin; Peter Foehr; Olaf Brinkmann; Matthias Bungartz; Rainer H Burgkart; T Graeve; Raimund W Kinne
Journal:  Cartilage       Date:  2018-02-20       Impact factor: 4.634

Review 3.  Cell-based tissue engineering strategies used in the clinical repair of articular cartilage.

Authors:  Brian J Huang; Jerry C Hu; Kyriacos A Athanasiou
Journal:  Biomaterials       Date:  2016-04-26       Impact factor: 12.479

4.  Short-term follow up after implantation of a cell-free collagen type I matrix for the treatment of large cartilage defects of the knee.

Authors:  Philip P Roessler; Bernhard Pfister; Markus Gesslein; Jens Figiel; Thomas J Heyse; Christian Colcuc; Olaf Lorbach; Turgay Efe; Karl F Schüttler
Journal:  Int Orthop       Date:  2015-02-13       Impact factor: 3.075

5.  Cell-free collagen type I matrix for repair of cartilage defects-clinical and magnetic resonance imaging results.

Authors:  Turgay Efe; Christina Theisen; Susanne Fuchs-Winkelmann; Thomas Stein; Alan Getgood; Marga B Rominger; Jürgen R J Paletta; Markus D Schofer
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-11-18       Impact factor: 4.342

6.  Use of cell-free collagen type I matrix implants for the treatment of small cartilage defects in the knee: clinical and magnetic resonance imaging evaluation.

Authors:  Karl F Schüttler; Hanno Schenker; Christina Theisen; Markus D Schofer; Alan Getgood; Philip P Roessler; Johannes Struewer; Marga B Rominger; Turgay Efe
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-11-07       Impact factor: 4.342

7.  [Trauma sequalae after complex knee ligament injuries].

Authors:  M Jagodzinski; M Ettinger; E Liodakis; N Hawi; M Petri; C Krettek
Journal:  Unfallchirurg       Date:  2013-05       Impact factor: 1.000

8.  [Defect models for the regeneration of articular cartilage in large animals].

Authors:  B Schneider-Wald; A K von Thaden; M L R Schwarz
Journal:  Orthopade       Date:  2013-04       Impact factor: 1.087

9.  Hip Chondral Defects: Arthroscopic Treatment With the Needle and Curette Technique and ChondroFiller.

Authors:  Luis Perez-Carro; Paola Rosi Mendoza Alejo; Gustavo Gutierrez Castanedo; Guillermo Menendez Solana; Jose Antonio Fernandez Divar; Pablo Galindo Rubin; Ana Alfonso Fernandez
Journal:  Arthrosc Tech       Date:  2021-06-20

10.  Repair of a chondral defect using a cell free scaffold in a young patient--a case report of successful scaffold transformation and colonisation.

Authors:  Karl F Schüettler; Johannes Struewer; Marga B Rominger; Peter Rexin; Turgay Efe
Journal:  BMC Surg       Date:  2013-04-16       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.